Artemis Therapeutics, Inc.·4

Mar 19, 4:15 PM ET

Morris Chanan 4

4 · Artemis Therapeutics, Inc. · Filed Mar 19, 2018

Insider Transaction Report

Form 4
Period: 2018-03-15
Morris Chanan
Chief Financial Officer
Transactions
  • Award

    Stock Option (Right to Buy)

    2018-03-15+50,00050,000 total
    Exercise: $1.30Exp: 2028-03-15Common Stock (50,000 underlying)
Footnotes (1)
  • [F1]The option, representing a right to purchase 50,000 shares of the Issuer's common stock at an exercise price of $1.30 per share, vests ratably over a 48 month period commencing on the first day of the month beginning on February 1, 2018.

Documents

1 file
  • 4
    zk1821373.xmlPrimary

    OWNERSHIP DOCUMENT